We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Clinical track: CNS
9301
Poster
Clinical
00:00 - 00:00
POSTOPERATIVE STEREOTACTIC BRAIN RADIATION THERAPY: A SINGLE CENTRE RETROSPECTIVE ANALYSIS
PO-0859
00:00 - 00:00
Leptomeningeal disease following stereotactic radiotherapy for resected brain metastases
PO-0857
00:00 - 00:00
Radiation-induced meningiomas: outcomes following stereotactic radiosurgery
PO-0855
00:00 - 00:00
Stereotactic Radiotherapy for Treatment of Brain Metastases: a monocentric experience
PO-0858
00:00 - 00:00
Radiochemotherapy retreatment in high grade giomas recurrences
PO-0863
00:00 - 00:00
Analysis of inter-observer variation from meningioma eContouring session
PO-0856
00:00 - 00:00
Clinical outcome of anaplastic oligodendroglioma treated with adjuvant radiotherapy and temozolomide
PO-0862
00:00 - 00:00
SRS alone of brain metastases with unfavorable prognostic factors
PO-0864
00:00 - 00:00
The relation between post-radiation injury and postoperative ischemia in diffuse glioma treatment
PO-0866
00:00 - 00:00
Survival outcomes and prognosis in patients with triple-negative breast cancer and brain metastases
PO-0865
00:00 - 00:00
Hippocampal dose reduction while treating brain gliomas using 3DCRT
PO-0860
00:00 - 00:00
Survival outcomes after upfront stereotactic radiosurgery for brain metastases from breast cancer
PO-0861
00:00 - 00:00
Leptomeningeal metastases of breast and lung cancer- a retrospective analysis
PO-0886
00:00 - 00:00
Protontherapy in Vestibular Schwannoma: volume changes, control rate, toxicity, hearing preservation
PO-0888
00:00 - 00:00
Clinical outcome of diffuse midline glioma, H3K27M-mutant treated with post-operative radiotherapy
PO-0889
00:00 - 00:00
Application of radiation therapy to brain metastases with parallel or non-parallel PD-1 inhibition
PO-0891
00:00 - 00:00
Hypofractionated stereotactic radiotherapy for meninigioma, multicentric serie
PO-0892
00:00 - 00:00
Radiation therapy in meningioma- single center prospective and retrospective analysis
PO-0893
00:00 - 00:00
Survival in patients with NSCLC with brain metastases treated with WBRT
PO-0894
00:00 - 00:00
GPA in brain metastases treated with Stereotactic Radiosurgery
PO-0895
00:00 - 00:00
Radionecrosis in brain metastases treated with Stereotactic radiosurgery
PO-0896
00:00 - 00:00
Dosimetric Consequence of Transient Post-Surgical Anatomical Effects for Glioblastoma
PO-0897
00:00 - 00:00
Primary tumor-status relevance in NSCLC with brain metastases undergoing radiosurgery
PO-0898
00:00 - 00:00
Risk of brain Radionecrosis after radiosurgery in oligometastatic patients
PO-0899
00:00 - 00:00
Radionecrosis in patients with brain metastases treated with stereotactic radiotherapy.
PO-0900
00:00 - 00:00
Stereotactic radiotherapy in brain metastases. Survival and radiological behavior analysis.
PO-0901
00:00 - 00:00
Prognostic value of SVZ involvement in relation to tumor volume defined by MRI and FET PET in GBM
PO-0902
00:00 - 00:00
CELLULAR PHONEs RADIOFREQUENCY EXPOSURE AND MALIGNANT BRAIN TUMOR:SISTEMATIC REVIEW AND METAANALISYS
PO-0903
00:00 - 00:00
Irradiated brain volume is not related to the risk of radionecrosis: reconsidering the role of V12Gy
PO-0904
00:00 - 00:00
The impact of adjuvant radiotherapy on molecular prognostic markers in gliomas
PO-0905
00:00 - 00:00
MRI contrast clearance analysis for follow-up of brain tumors treated with VMAT and SRT
PO-0906
00:00 - 00:00
Relationship Between Glioblastoma Dose-volume Parameters Measured by FET-PET and Clinical Outcomes
PO-0907
00:00 - 00:00
Efficacy and Toxicity of Proton therapy and Tomotherapy combination in sacral chordoma patients
PO-0908
00:00 - 00:00
High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas
PO-0909
00:00 - 00:00
Impact of GTV on overall survival of Glioblastoma, post definitive therapy: a retrospective study.
PO-0870
00:00 - 00:00
Outcomes in Pineal Parenchymal tumours of intermediate differentiation: A single institution study
PO-0871
00:00 - 00:00
Craniopharyngiomas treated with Fractionated Stereotactic Radiotherapy (FSR)
PO-0872
00:00 - 00:00
Lung Cancer Brain Metastasis: Higher Biologically Effective Dose Radiotherapy may improve survival.
PO-0873
00:00 - 00:00
Development of a prognostic model for patients with high-grade meningioma - the ELSA study
PO-0874
00:00 - 00:00
Comparison of risk scores for re-irradiation of patients with recurrent high-grade gliomas (HGG)
PO-0875
00:00 - 00:00
Stereotactic radiosurgery with single-isocenter dynamic arc therapy of multiple brain metastases
PO-0876
00:00 - 00:00
Hypofractionated and single-fraction SRT for brain metastases with sex as a key predictor of OS
PO-0877
00:00 - 00:00
Improving dose distribution by adaptive radiotherapy for glioblastoma: A prospective study
PO-0878
00:00 - 00:00
Stereotactic radiotherapy for re-irradiation of relapsed intracranic lesions
PO-0879
00:00 - 00:00
Risk of Symptomatic Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases
PO-0867
00:00 - 00:00
SRS in brain metastases from colorectal-cancer. A Radiation Oncology Italian Association study
PO-0880
00:00 - 00:00
Volumetric evaluation after hypofractionated radiotherapy for meningioma treated by Cyberknife
PO-0868
00:00 - 00:00
Assessment of results of radiosurgery for brain metastases from primary lung cancer
PO-0869
00:00 - 00:00
Visual outcomes in anterior visual pathway meningioma with standard vs hypofractionated FSR regimens
PO-0881
00:00 - 00:00
Single centre review of the survival benefit and toxicity of PCI in Small Cell Lung Cancer
PO-0882
00:00 - 00:00
Early outcomes in patients with skull base chordomas and chondrosarcomas treated with proton therapy
PO-0883
00:00 - 00:00
Risk of radionecrosis in brain metastases treated with SRT and systemic therapy
PO-0884
00:00 - 00:00
Radiation-induced edema in reirradiation of recurrent high-grade gliomas treated with Proton therapy
PO-0885